hyperuricemia


Also found in: Dictionary, Medical, Wikipedia.
Related to hyperuricemia: purine, uric acid

hyperuricemia

[¦hī·pər‚yu̇r·ə′sē·mē·ə]
(medicine)
Abnormally high level of uric acid in the blood. Also known as lithemia.
References in periodicals archive ?
Members voted 14-0 that the data in the four pivotal phase III trials submitted to the FDA contained enough evidence of a clinically meaningful beneficial effect of lesinurad in combination with a xanthine oxidase inhibitor (XOI) in the treatment of hyperuricemia associated with gout.
About GUAES The Gout & Uric Acid Education Society is a nonprofit organization of health care professionals dedicated to educating the public and health care community about gout -- the most common form of inflammatory arthritis -- and the related consequences of hyperuricemia.
Gout expert input should be sought, at minimum, when the cause of hyperuricemia is unclear, when gout signs or symptoms are refractory, when there is difficulty achieving serum urate target (especially in patients with chronic kidney disease), or when there are multiple or serious adverse events from therapy.
It usually begins as self-limited attacks of acute inflammatory arthritis, but the long-standing hyperuricemia causes erosive polyarthritis and chronic tophaceous forms of the disease in some patients.
Researchers said hyperuricemia has been associated with metabolic syndrome, hypertension, type 2 diabetes mellitus, chronic kidney disease, gout, and cardiovascular morbidity and mortality.
Hyperuricemia has been associated with metabolic syndrome, hypertension, type 2 diabetes, mellitus, chronic kidney disease, gout, and cardiovascular morbidity and mortality.
Several medications such as diuretics, low-dose aspirin, and anti-tuberculosis drugs have been associated with the development of hyperuricemia and gout.
said it has signed exclusive distributorship agreements to expand the global marketing of its proprietary TMX-67 drug for the treatment of hyperuricemia and gout to Turkey, Mexico and the Caribbean, Middle Eastern and North African regions from the United States, Britain, Germany and six other countries.
TMX-67 is the first drug indicated for treatment of hyperuricemia with or without symptoms (e.
6,7) Hyperuricemia predicts mortality in patients with heart failure or coronary heart disease, cerebrovascular events in individuals with diabetes, and cardiac ischemia in hypertension (8-10).